Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes

Clinical and Experimental Immunology

Volumn 174, Issue 2, 2013, Pages 302-317

  Di Caro, V ^a,d   Phillips, B ^c   Engman, C ^a   Harnaha, J ^a   Trucco, M ^a   Giannoukakis, N ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d RiMED Foundation   (Italy)

Author keywords

Antigen presenting cells; Autoimmunity; B cells; Immunomodulation; Immunosuppressive

Indexed keywords

RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL;

ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; B CELLS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE;

ANTIGENS, CD19; ANTIGENS, CD24; ANTIGENS, CD38; B-LYMPHOCYTES, REGULATORY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; T-LYMPHOCYTES, REGULATORY; TRETINOIN;

EID: 84885094363     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12177     Document Type: Article

References (66)

1. Marino E, Grey ST. B cells as effectors and regulators of autoimmunity. Autoimmunity 2012; 45:377-387.
2. Salinas GF, Braza F, Brouard S, Tak PP, Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin Immunol 2012; 146:34-45.
3. Dorner T, Jacobi AM, Lee J, Lipsky PE. Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods 2011; 363:187-197.
4. Radic M, Herrmann M, van der Vlag J, Rekvig OP. Regulatory and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity 2011; 44:349-356.
5. Aringer M, Burkhardt H, Burmester GR etal. Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland - a consensus report. Lupus 2012; 21:386-401.
6. Calero I, Sanz I. Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? Discov Med 2010; 10:416-424.
7. Lo MS, Tsokos GC. Treatment of systemic lupus erythematosus: new advances in targeted therapy. Ann NY Acad Sci 2012; 1247:138-152.
8. Looney RJ, Anolik J, Sanz I. A perspective on B cell-targeting therapy for SLE. Mod Rheumatol 2010; 20:1-10.
9. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997; 46:941-946.
10. Serreze DV, Chapman HD, Varnum DS etal. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new 'speed congenic' stock of NOD.Ig mu null mice. J Exp Med 1996; 184:2049-2053.
11. Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 1998; 161:1163-1168.
12. Marino E, Batten M, Groom J etal. Marginal-zone B cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T cells. Diabetes 2008; 57:395-404.
13. Noorchashm H, Lieu YK, Noorchashm N etal. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 1999; 163:743-750.
14. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998; 161:3912-3918.
15. Silveira PA, Johnson E, Chapman HD, Bui T, Tisch RM, Serreze DV. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol 2002; 32:3657-3666.
16. Tian J, Zekzer D, Lu Y, Dang H, Kaufman DL. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J Immunol 2006; 176:2654-2661.
17. Greeley SA, Katsumata M, Yu L etal. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002; 8:399-402.
18. Inoue Y, Kaifu T, Sugahara-Tobinai A, Nakamura A, Miyazaki J, Takai T. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. J Immunol 2007; 179:764-774.
19. Ryan GA, Wang CJ, Chamberlain JL etal. B1 cells promote pancreas infiltration by autoreactive T cells. J Immunol 2010; 185:2800-2807.
20. Hu CY, Rodriguez-Pinto D, Du W etal. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 2007; 117:3857-3867.
21. Xiu Y, Wong CP, Bouaziz JD etal. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol 2008; 180:2863-2875.
22. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H etal. Rituximab, B lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009; 361:2143-2152.
23. Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 2010; 6:636-643.
24. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 2010; 1183:38-57.
25. Iwata Y, Matsushita T, Horikawa M etal. Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011; 117:530-541.
26. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28:639-650.
27. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182:7459-7472.
28. Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol 2007; 179:7225-7232.
29. Bleesing JJ, Fleisher TA. Human B cells express a CD45 isoform that is similar to murine B220 and is downregulated with acquisition of the memory B cell marker CD27. Cytometry B Clin Cytom 2003; 51:1-8.
30. Bleesing JJ, Morrow MR, Uzel G, Fleisher TA. Human T cell activation induces the expression of a novel CD45 isoform that is analogous to murine B220 and is associated with altered O-glycan synthesis and onset of apoptosis. Cell Immunol 2001; 213:72-81.
31. Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011; 34:2026-2032.
32. Blair PA, Norena LY, Flores-Borja F etal. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010; 32:129-140.
33. Evans JG, Chavez-Rueda KA, Eddaoudi A etal. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178:7868-7878.
34. Moreb JS, Ucar D, Han S etal. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact 2012; 195:52-60.
35. Moreb JS, Zucali JR, Ostmark B, Benson NA. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay. Cytometry B Clin Cytom 2007; 72:281-289.
36. Bonhoeffer S, Mohri H, Ho D, Perelson AS. Quantification of cell turnover kinetics using 5-bromo-2′-deoxyuridine. J Immunol 2000; 164:5049-5054.
37. Nguyen XD, Eichler H, Dugrillon A, Piechaczek C, Braun M, Kluter H. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods 2003; 275:57-68.
38. Tough DF, Sprent J, Stephens GL. Measurement of T and B cell turnover with bromodeoxyuridine. Curr Protoc Immunol 2007; Chapter 4:Unit 4 7.
39. Ballow M, Wang X, Xiang S, Allen C. Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells. J Clin Immunol 2003; 23:46-54.
40. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012; 30:221-241.
41. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced Treg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007; 204:1765-1774.
42. Collins CB, Aherne CM, Kominsky D etal. Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Gastroenterology 2011; 141:1821-1831.
43. Golovina TN, Mikheeva T, Brusko TM, Blazar BR, Bluestone JA, Riley JL. Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS ONE 2011; 6:e15868.
44. Kawazoe Y, Sugita S, Keino H etal. Retinoic acid from retinal pigment epithelium induces T regulatory cells. Exp Eye Res 2012; 94:32-40.
45. Lu L, Zhou X, Wang J, Zheng SG, Horwitz DA. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-beta and retinoic acid. PLoS ONE 2010; 5:e15150.
46. Wang G, Zhong A, Wang S, Dong N, Sun Z, Xia J. Retinoic acid attenuates acute heart rejection by increasing regulatory T cell and repressing differentiation of Th17 cell in the presence of TGF-beta. Transpl Int 2010; 23:986-997.
47. Mora JR, Iwata M, Eksteen B etal. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006; 314:1157-1160.
48. Somenzi G, Sala G, Rossetti S, Ren M, Ghidoni R, Sacchi N. Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid. PLoS ONE 2007; 2:e836.
49. El-Amine M, Melo M, Kang Y, Nguyen H, Qian J, Scott DW. Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J Immunol 2000; 165:5631-5636.
50. Maseda D, Smith SH, DiLillo DJ etal. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 2012; 188:1036-1048.
51. Berger TG, Schulze-Koops H, Schafer M, Muller E, Lutz MB. Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro. PLoS ONE 2009; 4:e6645.
52. Tiurbe G, Matuschek A, Kammerer U etal. Inhibitory effects of rat bone marrow-derived dendritic cells on naive and alloantigen-specific CD4+ T cells: a comparison between dendritic cells generated with GM-CSF plus IL-4 and dendritic cells generated with GM-CSF plus IL-10. BMC Res Notes 2009; 2:12.
53. Yokota A, Takeuchi H, Maeda N etal. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity. Int Immunol 2009; 21:361-377.
54. Bai A, Lu N, Guo Y, Liu Z, Chen J, Peng Z. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol 2009; 86:959-969.
55. Chen Z, Lin F, Gao Y etal. FOXP3 and RORgammat: transcriptional regulation of Treg and Th17. Int Immunopharmacol 2011; 11:536-542.
56. Volchenkov R, Karlsen M, Jonsson R, Appel S. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scand J Immunol 2013; 77:246-254.
57. Giannoukakis N, Trucco M. A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2012; 19:279-287.
58. Ray A, Basu S, Williams CB, Salzman NH, Dittel BN. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 2012; 188:3188-3198.
59. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 2007; 178:3447-3456.
60. Song L, Wang J, Wang R etal. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? Gene Ther 2004; 11:1487-1496.
61. Soukhareva N, Jiang Y, Scott DW. Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells. Cell Immunol 2006; 240:41-46.
62. Tu W, Lau YL, Zheng J etal. Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 2008; 112:2554-2562.
63. Zheng J, Liu Y, Qin G etal. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol 2009; 183:3742-3750.
64. Blair PA, Chavez-Rueda KA, Evans JG etal. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009; 182:3492-3502.
65. Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol 2004; 173:4331-4341.
66. Yoshizaki A, Miyagaki T, DiLillo DJ etal. Regulatory B cells control T cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012; 491:264-268.